Rational Design and In Vivo Characterization of mRNA-Encoded Broadly Neutralizing Antibody Combinations against HIV-1

Monoclonal antibodies have been used successfully as recombinant protein therapy; however, for HIV, multiple broadly neutralizing antibodies may be necessary. We used the mRNA-LNP platform for in vivo co-expression of 3 broadly neutralizing antibodies, PGDM1400, PGT121, and N6, directed against the...

Descripción completa

Detalles Bibliográficos
Autores principales: Narayanan, Elisabeth, Falcone, Samantha, Elbashir, Sayda M., Attarwala, Husain, Hassett, Kimberly, Seaman, Michael S., Carfi, Andrea, Himansu, Sunny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680504/
https://www.ncbi.nlm.nih.gov/pubmed/36412833
http://dx.doi.org/10.3390/antib11040067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680504/
https://www.ncbi.nlm.nih.gov/pubmed/36412833
http://dx.doi.org/10.3390/antib11040067

Ejemplares similares